$ Value
$26K
Shares
3,086
Price
$8
Filed
Sep 18
Insider
Name
Harmon Cyrus
Title
—
CIK
0001831410
Roles
Transaction Details
Transaction Date
2025-09-18
Code
S
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
117,028
Footnotes
The weighted average sale price for the transaction reported was $8.04, and the range of prices was between $8.02 and $8.09. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. | The weighted average sale price for the transaction reported was $8.33, and the range of prices was between $8.28 and $8.37. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. | The weighted average sale price for the transaction reported was $8.08, and the range of prices was between $8.04 and $8.08. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. | The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager. | The weighted average sale price for the transaction reported was $8.32, and the range of prices was between $8.29 and $8.33. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
Filing Info
Harmon Cyrus's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-20 | OLMA | ▼ | $269K |
| 2026-01-14 | OLMA | ▼ | $102K |
| 2025-12-22 | OLMA | ▼ | $82K |
| 2025-09-18 | OLMA | ▼ | $83K |
| 2025-09-18 | OLMA | ▼ | $26K |
| 2025-09-16 | OLMA | ▼ | $80K |
| 2025-09-16 | OLMA | ▼ | $15K |
| 2025-06-11 | OLMA | A | $0 |
Other Insiders at OLMA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Mitchell Shawnte
CHIEF LEGAL OFFICER
|
— | — | 2026-02-02 |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
— | — | 2026-02-02 |
|
Bohen Sean
PRESIDENT AND CEO
|
— | — | 2026-02-02 |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER
|
— | — | 2026-02-02 |